glp 1 beta cell regeneration JCI Insight Pancreatic β cell regeneration induced

A 2023 analysis of semaglutide users found that approximately 1520% experienced moderate gastrointestinal symptoms during the first 8 weeks, and adding an NSAID during this sensitive period increased symptom severity by 3040%

Glucagon and GLP-1 inhibit food intake and increase c-fos expression in similar appetite regulating centres in the brainstem and amygdala

Patients treated with TOUJEO used 18% more basal insulin than patients treated with LANTUS

Evaluating drug-drug interaction risk associated with peptide analogues using advanced in vitro systems

A note on the category The GLP-1 supplement space has grown rapidly alongside broader consumer interest in GLP-1 medications

WEDNESDAY, June 10, 2026 (HealthDay News) -- Continuation of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) into early pregnancy seems not to be associated with the risk for nonlive birth, abnormal fetal growth, or major congenital malformation (MCM), according to a study published online June 9 in the Annals of Internal Medicine.Jeremy P